| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Meridian Health Services provides a safe, medically-supervised environment that respects your privacy and supports your physical and emotional health.
V&P Scientific is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For the guaranteed low membership price of only $19.99 a month, you can have an elite gym experience unlike anywhere else. Our Retro Fitness locations are home to state-of-the-art fitness equipment, cardio movie theaters, group classes, Retro Blends Ju...
Indiana Health Information Exchange operates the nation’s largest health information exchange, providing a secure, robust and interoperable health information technology network that connects over 100 hospitals, long-term care facilities, rehabilitation centers, community health clinics and other healthcare providers. IHIE provides the nation’s largest implementation of clinical results delivery in the country (DOCS4DOCS® Service). The organization supports the Indiana Network for Patient Care, a clinical data repository accessed via IHIE’s CareWeb application. IHIE also provides Public Health, Transitions of Care and Population Health Management Services.